Where does Symed Labs Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Symed Labs Limited ranks #33,498 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Symed Labs Limited hold?

Symed Labs Limited holds 8 US utility patents granted between 2015 and 2017, spanning 3 technology areas.

What is Symed Labs Limited's Innovation Score?

Symed Labs Limited has an Innovation Score of 21.4 out of 100 (8th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Symed Labs Limited focus on?

Symed Labs Limited's top technology area is C07D (Heterocyclic Compounds) with 8 patents, ranking #998 of 3,165 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

Is Symed Labs Limited's patent grant rate increasing or decreasing?

Symed Labs Limited's recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Symed Labs Limited's patents?

Symed Labs Limited's patents average 12.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Symed Labs Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Symed Labs Limited

USPTO PatentsView assignee record - 8 granted patents across 3 technology areas, recorded in grant years 2015–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Symed ranks #33,498 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 3 technology areas.

#33,498
of 49,997 US assignees by volume: 8th percentile
by Innovation Score (21.4/100): 12.9
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R33498 · Foreign Corporation #33,498 · 8 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 8 grants
MID-PACK #33,498/49,997
PHOTO-FINISH Swallow Incubate
CPC-NARROW C07D · 3 areas
INNOV-THIN 21.4/100
CLAIMS-RICH 12.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Swallow Incubate Co., Ltd (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Symed’s 21.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.6 pts (36%) Velocity 0.0 pts (0%) Breadth 6.1 pts (29%) Claim depth 7.7 pts (36%)

Qualcomm Incorporated · highest

85
Symed Labs · this assignee

21
3D Lighting… · lowest

7

What this shows Symed's Innovation Score is 21.4/100 (8th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Symed?

Each dot is one of Symed’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Symed’s own 12.9 claims/patent is at or below the 14.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Symed vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Symed's grants concentrate

Symed Labs Limited is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2016 (4 grants) versus a trough of 1 in 2015. By volume, Symed sits between Swallow Incubate Co., Ltd and Synqy Corporation.

Swallow Incubate

8
SWF Industrial

8
Sylvan America

8
Symbiont IO

8
SYN Trac

8
Syndaver Labs

8
Syndefense

8
Synqy

8
Symed Labs ◀

8

What this shows Symed holds 8 patents at rank #33,300, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Symed

By rank, the assignees closest to #33,300 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in Symed's primary technology class.

Symed's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

21 8th percentile higher than 8% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Symed Labs Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	12.5%
2016	4	50.0%
2017	3	37.5%

Which technologies does Symed Labs Limited patent most?

C07D - Heterocyclic Compounds 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

C07C - Acyclic OR Carbocyclic Compounds 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Symed Labs Limited's patent record in context - here's where to go next.

Symed Labs Limited's lead technology class is C07D (Heterocyclic Compounds), 100% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #33,498 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Symed Labs Limited against Swallow Incubate Co., Ltd, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 21.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.